The abstract is read at the publisher; the summary is JClub's.
Ferroptotic cancer cells trigger p38 MAPK–dependent prostaglandin E2 (PGE2) production, which suppresses type 1 conventional dendritic cell–driven CD8+ T cell stimulation and enables immune escape.
- Why it matters: Ferroptosis-inducing therapies can be undermined by ferroptotic cells that limit anticancer immunity, but the mechanism behind this immune escape has been unclear.
- What they did: The authors show that lipid peroxidation–mediated membrane permeabilization allows Ca2+ influx, activating p38 MAPK to drive PGE2 production, and they test targeting this axis to block immune inhibition.
- The result: Ablating PGE2 production or disrupting PGE2 signalling restores cDC1-mediated CD8+ T cell responses and enables effective tumour elimination when ferroptosis is induced in cancer cells.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.